INFORMATION SYSTEMS FOR BIOTECHNOLOGY


February 2000
NEWS FOR THE AGRICULTURAL AND ENVIRONMENTAL BIOTECHNOLOGY COMMUNITY


IN THIS ISSUE:
ISB Receives Science Magazine Commendation
Global Treaty Adopted on Genetically Modified
EPA Restrictions on Bt Corn Announced
$180 Million Dedicated to USDA Projects
Roger Beachy Named R&D's "Scientist of the Year"
Attacks on GE Research Facilities Heat Up
A Sweeter Deal Than Expected from Transgenic Sugar Beets
Tandem Constructs for Superweed Prevention
New Troubles for Bt Corn?
In Search of Horizontal Gene Transfer
Production of Foreign Protein in Seminal Fluid
GM Product Labeling Caters Food for Thought



ISB RECEIVES SCIENCE MAGAZINE COMMENDATION

A short article in the December 17, 1999 issue of Science magazine lauds the Information Systems for Biotechnology Web site as one that ". . . cuts through the hype over bioengineered foods" and ". . . strives for middle-of-the-road perspective." The article, featured in the NetWatch section of the highly acclaimed journal, describes the News Report as a standout feature of the site. It also cites the usefulness of the database of proposed field trials of GM crops, with additional mention made of the risk assessment section, workshop proceedings, and biosafety committee list found at the site. ISB gratefully acknowledges this recognition.


GLOBAL TREATY ADOPTED ON GENETICALLY MODIFIED ORGANISMS

Montreal, 29 January 2000 - After five years of talks, ministers and senior officials from over 130 governments have finalized a legally binding agreement for protecting the environment from risks posed by the transboundary transport of living modified organisms (LMOs) created by modern biotechnology.

Under the Cartagena Protocol on Biosafety, governments will signal whether or not they are willing to accept imports of agricultural commodities that include LMOs by communicating their decision to the world community via an Internet-based Biosafety Clearing House. In addition, shipments of these commodities that may contain LMOs are to be clearly labeled.

Stricter Advanced Informed Agreement procedures will apply to seeds, live fish, and other LMOs that are to be intentionally introduced into the environment. In these cases, the exporter must provide detailed information to each importing country in advance of the first shipment, and the importer must then authorize the shipment. The aim is to ensure that recipient countries have both the opportunity and the capacity to assess risks involving the products of modern biotechnology.

"This agreement goes a long way towards meeting the environmental concerns of the international community," said Klaus Toepfer, Executive Director of the United Nations Environment Programme (UNEP), which administers the secretariat of the Convention on Biological Diversity, under whose auspices the talks took place.

One of the most contentious issues that negotiators had to resolve involved the relationship between the Protocol and other international agreements, notably those under the World Trade Organization. While environmental agreements are premised on the precautionary principle, decisions under trade law require "sufficient scientific evidence." Under the new agreement, the Protocol and the WTO are to be mutually supportive; at the same time, the Protocol is not to affect the rights and obligations of governments under any existing international agreements.

The meeting was attended by over 700 delegates from governments as well as from intergovernmental and non-governmental organizations. Over 40 ministers attended during the final two days.The agreed text of the Biosafety Protocol will be opened for signature at UNEP headquarters in Nairobi from 15 - 26 May, on the occasion of the Fifth Session of the Conference of the Parties to the Convention on Biological Diversity (COP 5). The Protocol will then enter into force for its members after 50 countries have ratified it.

Press Release
Convention on Biological Diversity
http://www.biodiv.org


EPA RESTRICTIONS ON Bt CORN ANNOUNCED

In response to concerns that Bt corn may be accelerating the evolution of pesticide resistant insects, the EPA has announced new restrictions on GE corn cultivation. The new restrictions, which became effective January 14th, require registrants to ensure that growers plant a minimum of 20 percent of their acreage in non-Bt corn refuges. For corn grown in cotton areas, the non-Bt refuge requirement is increased to at least 50 percent. In addition, registrants have been asked to expand monitoring for any potential insect resistance and communicate any voluntary measures taken to protect non-target insects, particularly the Monarch butterfly.

Response from the agriculture industry has been positive. This statement was issued by the National Corn Growers Association: "NCGA strongly supports the planting of [Insect Resistance Management] refuges because they allow the maximum use of this pest control technology while maintaining its long-term effectiveness," said Fred Yoder, Plain City, Ohio, farmer and a member of NCGA's Corn Board. "We welcome EPA's statement because it generally follows the plan we submitted. The EPA's announcement actually validates those recommendations." (See: NCGA Welcomes EPA Biotech Decision. http://www.ncga.com/archives/news000115.html)

For more information on EPA's biotechnology regulatory program for plant pesticides, see: http://www.epa.gov/pesticides/biopesticides


$180 MILLION DEDICATED TO USDA PROJECTS

Agriculture Secretary Dan Glickman unveiled plans for $180 million in new USDA investments in projects aimed at boosting the rural economy, promoting agricultural research, and developing new agricultural products and practices for the future.

Glickman awarded $60 million in Fund for Rural America research and economic development grants. The remaining $120 million will be distributed through a competitive grant process under the Secretary's new Initiative for Future Agriculture and Food Systems. The USDA will issue a request for proposals to solicit specific project proposals for the Initiative later this year. The Initiative will fund competitive research, education, and extension grants that focus on production agriculture, natural resource management, and consumer issues.

The Initiative's priorities include:
• Agricultural genomics and biotechnology risk assessment
• Food safety and the role of nutrition in health
• New uses for agricultural products, including biomass fuel sources
• Natural resources management, pest management, and precision agriculture
• Farm efficiency and profitability, with an emphasis on small- and mid-sized family farms

See: http://www.usda.gov/news/releases/2000/01/0007


ROGER BEACHY NAMED R&D'S "SCIENTIST OF THE YEAR"

Roger Beachy, President of the Donald Danforth Plant Science Center in St. Louis, was selected by R&D magazine as "1999 Scientist of the Year" for his technology transfer achievements in plant genetics. R&D Magazine is a monthly trade journal serving commercial and governmental research and development scientists. Beachy has extensive academic and industrial experience in plant genetics and plant pathology and is credited with developing one of the earliest GM crops, a virus-resistant tomato, in a cooperative project with Monsanto. Much of Beachy's GMO work is aimed at agricultural technology transfer, and he is commended for his achievements in the commercialization of promising genetic technologies and products.

Beachy is most noted for his innovative GMO advances intended for use in developing nations. He is a strong proponent of using transgenic plants carrying pesticidal traits and herbicide resistant genes, which he views as a safe and environmentally sound technology for increasing crop yield in developing countries. The November R&D article about Beachy's award is available online at http://www.rdmag.com.

Brian R. Shmaefsky
Department of Biology and Environmental Sciences
Kingwood College
bshmaefs@nhmccd.edu


ATTACKS ON GE RESEARCH FACILITIES HEAT UP

A deliberately set fire has damaged the offices of the Agricultural Biotechnology Support Project (ABSP) based in Agriculture Hall at Michigan State University (MSU). The office of Catherine Ives, Director of ABSP and visiting professor at MSU, was the alleged target of the December 31, 1999 fire. An underground activist group known as the Earth Liberation Front (ELF) claimed credit for the property damage. The fire is currently under investigation by authorities including the Bureau of Alcohol, Tobacco, and Firearms, and Federal Bureau of Investigation. The press reported the damage estimate at approximately $400,000; however, "That's not official and is probably an underestimate," says Ives1.

The stated goals of the ELF organization are to "End GE!" and " . . . stop the systematic exploitation and destruction of the natural environment," according to a News Advisory posted on an Internet listserver maintained by the Bioengineering Action Network2. Actually, ELF only managed to set back progress on the USAID-funded project, which has been ongoing since 1991, by about a month. According to Ives, "Almost all the data was retrievable and we're back in business as usual in other offices."

In a communiqué issued by ELF and distributed by spokesperson Craig Rosebraugh, the group claimed Ives's offices were targeted in part because the ABSP project is funded by Monsanto and USAID. The communiqué states:

"On the eve of the new millenium [sic], the ELF struck back at one of the many threats to the natural world as we know it. On December 31, 1999 at approximately 9:00 pm, the ELF entered the Agricultural Hall at MSU in Lansing, Michigan. Our destination was room 324, the offices of Catherine Ives et al. The project being conducted through this office is funded by Monsanto and USAID and was designed to not only pursue research concerning genetically engineered sweet potatoes, corn and other crop vegetables, but to lobby developing countries to abandon their current agricultural practices and to rely on genetically engineered plants and thus corporations like Monsanto"3.

In fact, "We aren't funded by Monsanto," responds Ives. Of the approximately $20.8 million in funding the project has received over its life, 87.7% was from USAID and the rest obtained from matching MSU and private sector funds, and small grants. However, Monsanto is credited with giving the project a one-time sum of $2000 in travel money—not much, relative to $20.8 million, but enough, apparently, to incite the ire of ELF.

Ives also firmly rejects the claim that the USAID project encourages developing countries to ". . . abandon their current agricultural practices . . . ." Ives responds, "We do no such thing—we educate and train people in the use of molecular tools and the important regulatory issues that surround their safe and legal deployment. We recognize that biotechnology must be integrated into conventional, traditional systems. USAID is involved in the development and transfer of technologies that can assist in poverty alleviation, improved health, and promotion of a sustainable environment"1.

The attack at the MSU campus is not an isolated incident; although, given the potential for loss of life, it is one of the most disturbing to date. Most anti-GE activists' actions have focused on the destruction of GE crops, primarily at research sites. For example, on January 20th of this year, members of the Fragaria Freedom Fighters group claimed responsibility for the destruction of a field of genetically modified strawberries at Plant Sciences Inc. research facilities in California4. According to a statement released by the GenetiX Snowball Press Office, "This action is the 21st known action taken against genetically engineered crops and multinational biotechnology corporations in the last year"5.

Catherine Ives suggests researchers take a common sense approach to protect research facilities from similar attacks. She said they have been told to maintain a general vigilance, keep doors locked, and be on the look out for strangers who don't seem to have a reason for being in the area. "And above all, back up all data from your hard drive on a regular basis and keep copies in separate locations," stressed Ives. She added that if they had stored important papers, such as passports and supporting documents for their foreign staff, in a fire proof safe, many hassles would have been avoided.

Sources

1. Ives C. Pers. Comm. January 26, 2000. Ivesc@msu.edu

2. Bioengineering Action Network of North America. http://www.tao.ca/~ban (January 27, 2000)

3. BAN Listerver. ban@lists.tao.ca

4. Bioengineering Action Network of North America. http://www.tao.ca/~ban/100ARwatsonville.htm

5. King, Dylan. GenetiX Alert Press Office. galert@angelfire.com. GenetiX snowball. http://www.gn.apc.org/pmhp/gs/ (January 27, 2000)

Ruth Irwin
Information Systems for Biotechnology
Virginia Tech
rirwin@nbiap.biochem.vt.edu



A SWEETER DEAL THAN EXPECTED FROM TRANSGENIC SUGAR BEETS

The technical feasibility of producing novel products in traditional crops has been demonstrated many times, but in very few cases have these discoveries been put into commercial use. This is due to a number of factors, largely economic in nature. Few transgenic plants produce the compound of interest at a high enough level to offset the cost of processing, and in many cases the infrastructure necessary for processing the novel product simply does not exist. Now, recent experiments describing fructan production in transgenic sugar beet seem to satisfy all the demands for commercial production along with the possible side benefit of enhanced agronomic performance under conditions of drought stress.

Fructans are fructose polymers of commercial interest due to their promise as replacements for high calorie sweeteners and fats. Short chain fructans have the same sweet taste as sucrose, but provide no calories as humans lack the fructan-degrading enzymes necessary to digest them. The same is true for the longer chain fructans, which form emulsions having fat-like textures. Humans may not be able to utilize fructans, but the natural bacterial flora of the human gut can, resulting in a stimulation of their growth and leading to an increase in overall digestive health.

Currently, commercial production of small fructans from sucrose is carried out enzymatically in bioreacters using a fructosyl transferase isolated from Aspergillus niger. This production method is extremely expensive, resulting in a final cost for the compound that is too high for use in general foodstuffs. However, fructans accumulate naturally in about 15% of flowering plant species, including a number of traditional crop species such as wheat, onion, chicory, and Jerusalem artichoke, where they function primarily as a storage carbohydrate. The latter two species have been used for commercial extraction of fructans, but poor yield and complications with processing and product quality have ultimately rendered both plants economically unfeasible as sources.

Part of the problem with using natural sources for fructan extraction lies in the enzymes that control the synthesis and accumulation of these molecules. In plants, fructan synthesis occurs in the vacuole and begins with the conversion of sucrose to short fructose polymers through the action of 1-sucrose:sucrose fructosyl transferase (1-SST). A second enzyme, 1-fructan:fructan fructosyl transferase (1-FFT), is responsible for producing the longer chain forms of fructan by transferring fructosyl residues from one fructan molecule to another or to sucrose.

The combined action of these two enzymes results in a mix of fructans of different lengths, and additional enzymes cause branching or hydrolyze the chains to varying degrees. This mix of fructan end products causes problems for commercial manufacturers because a fairly homogeneous product is desirable. Consequently, additional processing is often necessary with fructans obtained from endogenous sources, driving up the cost of production.

With the cloning of cDNAs for 1-FFT and 1-SST from plant and bacterial sources, interest has grown in introducing these enzymes into plant backgrounds that do not normally synthesize fructans. The rationale behind this is that by introducing a single fructosyl transferase into a plant species devoid of fructan biosynthetic enzymes, it should be possible to produce a particular class of fructan molecules. The feasibility of this approach has been demonstrated by the introduction of fructosyl transferases from both bacterial and plant sources into tobacco, corn, and potato plants. However, in all these cases, the levels of fructan produced were not high enough to be economically useful or had deleterious effects on plant growth and development.

All photosynthetic plants synthesize sucrose, so any crop plant potentially could be engineered to produce fructan. However, sugar beet has several features that make it a logical choice. Sugar beet is bred to produce and store large amounts of sucrose, the precursor of fructan, and the majority of the sugar produced is stored in taproot cell vacuoles, the site of fructan synthesis. From a processing standpoint, the infrastructure already exists to extract and purify sugar compounds from beets. On the other hand, sugar beets are notoriously difficult to transform, a feature that has dissuaded a number of researchers from working with this species.

In an article in Nature Biotechnology, Koops and his colleagues described how they were able to overcome this hurdle by creating a transgenic line of sugar beet in which 40% of the taproot dry weight was converted to short chain fructans without discernible impact on plant growth or phenotype1. They utilized a stomatal guard cell-based method of transformation to introduce a construct containing a cDNA encoding 1-SST from Jerusalem artichoke. After regeneration of intact plants, eight independently transformed lines were recovered and demonstrated to contain between one and greater than eight copies of the transgene. Biochemical analysis confirmed that the inserted gene was expressed and functional in six of the eight lines. To verify that the plants were producing fructans, Koops and his colleagues performed both thin layer chromatography and high pressure anion exchange chromatography on extracts from taproot, the site of maximal sucrose production in wild type plants. They found that over 90% of the endogenous sucrose had been converted to small fructan molecules when compared with wild type lines, resulting in a yield of 110 µmol/g fresh weight. This impressive yield has led the authors to refer to their transgenic plants as "fructan beets" instead of sugar beets.

In a recent paper in Plant Physiology and Biochemistry, Pilon-Smits and her colleagues described a related set of experiments that point to a possible added agronomic benefit of these plants2. They also created fructan-producing sugar beets, this time using a bacterial fructosyl transferase instead of a plant fructosyl transferase. This enzyme, SacB, obtained from Bacillus subtilis, successfully catalyzed the production of long chain fructans in the transgenic plants. Though these plants displayed a relatively low level of fructan accumulation (0.5% dry weight in the highest-producing lines), they performed significantly better under conditions of drought stress when compared to wild type plants. Similar results were also reported previously for tobacco transformed to express fructan. The discovery of the drought tolerance benefit is not surprising as it has long been suggested that fructans of all lengths have a role in defending plants against drought stress in species that naturally accumulate these compounds. However, in most cases, it has been difficult to correlate increased levels of fructans with drought tolerance.

With this in mind, it will be interesting to establish whether the "fructan beets" created by Koops and co-workers will display an increase in drought tolerance to accompany their altered biochemical makeup. If not, the findings by Pilon-Smits may provide important insights into the chemical requirements of fructan-mediated drought tolerance. Either way, it seems that transgenic sugar beet may hold the promise of finally making useful compounds such as fructans more economically available.

Sources

1. Sevenier R, Hall RD, van der Meer IM, Hakkert HJC, van Tunen AJ, and Koops AJ. 1998. High level fructan accumulation in transgenic sugar beet. Nature Biotechnology 16:843-846

2. Pilon-Smits EAH, Terry N, Sears T, and van Dun K. 1999. Enhanced drought resistance in fructan-producing sugar beet. Plant Physiology and Biochemistry 37:313-317

Claire Granger
Carnegie Institution of Washington
Department of Plant Biology
claire@Andrew2.Stanford.edu


TANDEM CONSTRUCTS FOR SUPERWEED PREVENTION

Jonathan Gressel, of the Weizman Institute of Sciences in Israel, is well aware of one nightmare no farmer wants to encounter; he knows the bane of treating a field containing weeds not controllable with any available herbicide. Gessel's most recent paper, "Tandem constructs: Preventing the rise of superweeds," published in Trends in Biotechnology, brings some hope to prevention of superweed evolution1.

Gressel is a vocal proponent of plant biotechnology, yet much of his research assails a large biotechnology market—herbicide resistant crops. His argument, however, is not for limiting biotechnology, but instead for encouraging responsible biotechnology geared to make GMOs safe. Continuous herbicide use may lead to artificial selection of herbicide resistant weeds due to the reproductive advantage conferred on weeds possessing natural herbicide resistant genes. Studies show that many weed plants in the natural population contain these traits2,3.

Encouragement of superweed evolution by artificial selection is not the only argument leveled against using herbicide resistant crops. Gressel also is concerned that, "Transgenic crops may interbreed with nearby weeds," an opinion based on studies going back to 1986 suggesting transgenic traits can be horizontally transferred to wild relatives of domesticated plants. Scottish researchers were alerted to horizontal gene transmission following several field trials conducted in 1996 showing that pollen from genetically engineered rape traveled over 2.5 kilometers and fertilized other rape plants. The rape plant used in the study was developed for herbicide resistance. Population genetics studies conducted recently on cultivated and wild beet plants indicate the potential for this transfer between genetically engineered plants and weed relatives (see "Gene Flow Between Cultivated and Wild Beet," ISB News Report, December 1999.)

Some groups use evidence of horizontal gene transfer as grounds to protest the continued cultivation of transgenic crops. They argue that wild plant populations are being "genetically polluted" with traits not normally found in the population, and that may harm wild populations by causing extinction of the species, development of pest resistant plants, loss of economically useful alleles, and emergence of wild weed populations resistant to standard chemical control methods.

Gressel criticizes GMO risk analyses that ignore the utility of GE technology designed to prevent gene transfer. He postulates that gene transfer could be prevented in part by using tandem constructs; that is, the piggybacking of genes that affect germination by altering seed dormancy, ripening, and dissemination with genes for the desired trait in the construct. Other strategies include adding traits that cause dwarfing, inhibit flower production, prevent maturation, or induce pollen sterility. For example, an antibolting trait would work well to prevent the transmission of genes in biennials such as cabbage. Gressel notes that tandem constructs can also be used for further development of crops carrying traits for insect resistance and enhanced nutritional value.

Gressel supports using tandem constructs for what he coins "Transgenic Mitigation" because they: 1) are tightly linked and do not segregate separately; 2) use traits that are harmless to crops but deleterious to typical weeds; and 3) are disadvantageous to the successful reproduction of weeds within a population lacking the construct trait1,3. Gressel notes that many of the traits that are suitable as useful constructs are already mapped for numerous plants and can simply be attached to the desirable traits already engineered into crops.

Sources

1. Gressel J. 1999. Tandem constructs: Preventing the rise of superweeds. Trends in Biotechnology 17(9): 361-366.

2. Gressel J. 1988. Multiple resistances to wheat selective herbicides: New challenges to molecular biology. Oxford Surveys of Plant Molecular and Cell Biology 5:195-203.

3. Gressel J, Gardner S, and Mangel M. 1996. Prevention vs. remediation in resistance management. In Molecular Genetics and Ecology of Pesticide Resistance, ed. TM Brown. Washington, D.C.: American Chemical Society.

Brian R. Shmaefsky
Department of Biology and Environmental Sciences
Kingwood College
bshmaefs@nhmccd.edu


NEW TROUBLES FOR Bt CORN?

A study reported in December in the journal Nature seems poised to add fuel to the fiery debate over the possible environmental impact of Bt corn. In a brief communication to the journal, Guenther Stotzky and his colleagues report preliminary findings from a study indicating that root exudates from Bt corn contain biologically active Bt toxin and that the toxin retains its activity long after its release from the plant1.

There is increasing concern about the environmental impact of widespread cultivation of corn varieties engineered to constitutively express the insecticidal proteins of Bacillus thuringiensis. This is due largely to the publication of an article earlier this year, also in the journal Nature, that described how larvae of the Monarch butterfly were killed after feeding on milkweed leaves dusted with Bt corn pollen. The validity and relevance of this study has been hotly debated, but it has clearly stimulated greater interest in tracking the spread and persistence of Bt toxin in the environment as the result of the cultivation of these corn varieties.

Previous work by Dr. Stotzky and colleagues at New York University demonstrated that toxins from two separate strains of Bacillus thuringiensis are capable of persisting when introduced into a variety of soil types. By mixing Bt toxins with soils or soil components, they determined that the toxins bind to clays or humic acids in soils, and this binding process protects these compounds from microbial degradation, at least in a laboratory setting2. They also found that the insecticidal activity of the toxins, as determined by bioassay, was not affected by being bound to the soil particles. In fact, in a couple of cases the insecticidal activity of the toxin increased after binding3. However, the stability of the toxin's insecticidal activity varied widely, depending largely on the properties of the soils used in the experiments. Soils with more neutral pH values displayed a significant decrease in toxin activity within as little as 14 days, whereas soils with a more acidic pH value retained insecticidal activity for as long as six months.

In their latest study, described in Nature, Stotzky and co-authors reported finding biologically active Bt toxin that was released from the roots of Bt corn into growth medium and the soil environment. When Bt corn was grown in sterile liquid medium, the presence of Bt toxin was detected in the medium by performing a commercial immunological assay and an insecticidal bioassay on tobacco hornworm larvae.

No such protein was found when the growth medium from the corresponding non-Bt corn variety was analyzed. When similar tests were performed on soil samples surrounding the rhizosphere of Bt corn seedlings, they found similar Bt toxin activity, which persisted in the soil for at least 25 days. They concluded that the toxin may accumulate in soil under continuous cultivation of Bt corn and suggested that this accumulation may lead to unanticipated impacts on non-target organisms in the soil.

At least one anti-biotechnology group is already using the results from this paper as evidence of the potential for Bt corn to create widespread environmental damage4. However, this article describes results that are preliminary at best, and, in the absence of hard data, it is difficult to draw definitive conclusions from this work. Ultimately, determining the impact, if any, of Bt corn on soil fertility will require additional and far more extensive research under field conditions before verifiable conclusions can be reached.

Sources

1. Saxena D, Flores S, and Stotzky G. 1999. Insecticidal toxin in root exudates from Bt corn. Nature 402:480.

2. Crecchio C and Stotzky G. 1998. Insecticidal activity and biodegradation of the toxin from Bacillus thuringiensis subsp. kuristaki bound to humic acids from soil. Soil Biology and Biochemistry 30:463-470.

3. Tapp H and Stotzky G. 1998. Persistence of the insecticidal toxin from Bacillus thuringiensis subsp. kuristaki in soil. Soil Biology and Biochemistry 30:471-476.

4. Anonymous. 1999. GE crops with Bacillus thuringiensis (Bt) genes suspected to harm soil ecology. Physicians and Scientists for Responsible Application of Science and Technology. http://www.psrast.org/btsoilecol.htm

Claire Granger
Carnegie Institution of Washington
Department of Plant Biology
claire@Andrew2.Stanford.edu


IN SEARCH OF HORIZONTAL GENE TRANSFER

"Critics of agricultural biotechnology have often been dismissed as modern-day Luddites," proclaims Michael Syvanen in his commentary published in Nature Biotechnology1. Syvanen, a professor of medical microbiology and immunology at the University of California, Davis, defends the concerns of biotechnology opponents in his article titled, "In search of horizontal gene transfer." His commentary is offered in response to assertions made by several researchers and the US Food and Drug Administration (FDA) that horizontal gene transfer from plants to bacteria is not feasible. The FDA comment was referring to plant cells carrying antibiotic-resistance genes added to assist with the identification of transformed cells. These cells are eventually cultured into adult plants and released into the field.

The impact of horizontal gene transfer concerns agricultural biotechnology critics who claim that novel genes inserted into domesticated organisms might be transferred to wild organisms_an example would be the transfer of antibiotic resistance marker genes to soil bacteria. Studies supporting this argument are based on in vitro experiments, comparative gene frequency studies, and investigations of reproductive strategies2.

Syvanen's studies of bacterial and plant phylogeny indicate horizontal gene transfer is involved in evolutionary change. His work consists of numerous genetic studies dating back to the early 1980's, including recent genomic investigations on Archaea. Other researchers have reported evidence that functional chunks of DNA persist in the environment, and that significant quantities of plasmid DNA survived passage through a mouse digestive system and even stayed intact after macrophage ingestion. Although Syvanen concedes there are no confirmed studies of this type of gene transmission occurring in nature, he cautions that laboratory studies are evidence enough to warrant concern.

A disturbing consequence of horizontal gene transfer in bacteria is the potential for antibiotic resistance and other traits carried on plasmids to migrate from one type of bacterium to another. Evidence suggests genomic DNA is transmitted in nature. In bacteria, conjugation is the most likely mechanism responsible for gene transfer. Also, evidence of transfer of genetic material between unrelated prokaryotes and between Archaea and prokaryotes early in the evolution of prokaryotes may be explained by conjugation and the uptake of environmental DNA. In the introduction to Horizontal Gene Transfer, a book co-authored by Syvanen and Clarence Kado, reference is made to experimental evidence for plasmid transfer between E. coli and actinomycetes, Agrobacterium, and cyanobacteria2. The rapid diversification of eucaryotic evolution may have been accompanied by extensive gene transfer.

The possibility that gene transfer occurs between distantly related organisms such as bacteria and plants, or animals and plants, is the subject of speculation and debate. The most extensively studied mechanism of gene transfer from bacteria to plants is found in Agrobacterium, which readily transmits a plasmid that induces tumor development when incorporated into plants. Laboratory studies show that the bacteria are capable of transcribing and translating plant genes as well2.

Transposon-like elements are likely vehicles for cutting and pasting genomic DNA from one organism to another. Jeffrey Palmer of Indiana University suggests that a genetic parasite resembling a transposon can carry or "jump" a segment of yeast DNA into higher plants. Clarence Kado, a plant pathologist who has collaborated with Syvanen, believes viruses may be responsible for transmitting genes between eucaryotes. Also, a few scientists suspect that viral transmission of regulatory genes was involved in the macroevolution of metazoa. It is also believed that viruses may be responsible for the origin of introns in eucaryotic DNA. In fact, the theory that viruses are responsible for transmitting traits between unrelated organisms suggests that horizontal gene transfer could be a common event.

Molecular evolution estimates indicate that horizontal gene transmission is more likely to occur in microorganisms and plants. However, animal studies also provide evidence of the horizontal transmission of Drosophila P-elements. Syvanen likewise believes that gene transfer is probable, though not common, in humans and other animals.

Syvanen argues that some of the gene frequency studies, such as those examining neomycin phosphotransferase, provide weak evidence of the dangers of gene transfer because, "This gene is already ubiquitous, so it is far from clear that its presence in genetically engineered plants will add substantially to the existing danger." Though biotechnology opponents may use the implications from Syvanen's work to justify limiting the employment of GMOs, Syvanen himself does not condemn using GMOs in the field. He states, "If horizontal transfer is found out to occur naturally, perhaps the most significant outcome would be the reshaping of our evolutionary paradigms." However, Syvanen does argue, "If and when experiments prove that horizontal transfer occurs, the implications will be debatable. In such a scenario, some vectors might indeed create an unacceptable risk."

Sources

1. Syvanen M. 1999. In search of horizontal gene transfer. Nature Biotechnology, 17(9): 833.

2. Syvanen M and Kado CI. 1998. Horizontal gene transfer. London: Chapman & Hall.

3. Syvanen M. 1994. Horizontal gene transfer: Evidence and possible consequences. Annual Review of Genetics 28:237-261.

Brian R. Shmaefsky
Department of Biology and Environmental Sciences
Kingwood College
bshmaefs@nhmccd.edu



PRODUCTION OF FOREIGN PROTEIN IN SEMINAL FLUID

Transgenic animals are being developed as bioreactors for the production of important pharmaceutical proteins. The mammary gland is generally considered to be the tissue of choice because large volumes of milk can be easily collected. However, the production of milk-derived proteins is limited by the relatively long time interval from birth to first lactation and the discontinuous nature of the lactation cycle. Furthermore, the presence of casein micelles and fat globules in milk can complicate protein purification procedures. Therefore, alternative bodily fluids such as blood and urine have been explored as potential sites for foreign protein production.

In the November 1999 issue of Nature Biotechnology, researchers at the University of Laval in Quebec report the production of human growth hormone (hGH) in the seminal fluid of transgenic mice. Seminal fluid represents a promising alternative for the production of pharmaceutical proteins because it can be collected non-invasively and is available on a continuous basis.

In the article, the authors report that a hGH gene was fused to the promoter of a mouse protease inhibitor gene that is expressed in the accessory sex glands. This construct was used to produce four transgenic founder mice, three males and one female. Two of the founder males that secreted detectable levels of hGH in their seminal fluid and passed the transgene on to their progeny were further examined.

Expression of hGH was assayed in a number of different tissues of the transgenic mice. As expected, hGH mRNA and protein were detected in the seminal vesicles. However, unexpected expression of hGH was observed in the kidney. In addition, no pancreatic expression of hGH was detected although this protease inhibitor gene is reported to be constitutively expressed in this tissue.

The concentration of hGH in seminal fluid was measured for the two lines derived from the transgenic founder males. One male contained 240 µg/ml hGH in preejaculatory seminal fluid present within the seminal vesicle, while the other male contained 470 µg/ml. These concentrations of hGH represent 0.24 to 0.72% of the total protein in the seminal fluid. The level of hGH in ejaculates as measured by vaginal plug extracts was much lower, one to three µg/ml. However, the vaginal plug extract may not serve as an accurate assay of the true levels of hGH in seminal fluid.

Circulating concentrations of hGH were substantial and probably resulted from ectopic expression in the kidney. Samples from the blood of twelve week old male and female mice contained between 250 and 500 ng/ml hGH. These elevated levels of hGH resulted in a 23 to 77% increase in 12-week old body weights compared with non-transgenic mice.

This technology can now be applied to the production of transgenic pigs. Pigs are the species of choice because a boar ejaculates the largest volume of seminal fluid of all domestic livestock, averaging about 250 ml, reaches sexual maturity at 110-125 days of age, and can ejaculate two to three times per week year round. Assuming a production level of 0.5 µg/ml and two ejaculations of 250 ml per week, a single transgenic pig could produce 13 grams of protein per year.

These results demonstrate the potential for using seminal fluid as a target for foreign protein production. The side effects resulting from ectopic expression of the foreign protein, however, are an issue that still needs to be addressed. Nevertheless this report adds accessory sex glands to the list of previously reported tissues—mammary gland, blood, and bladder—which may be used as potential bioreactors.

Source

Dyck MK, et al. 1999. Seminal vesicle production and secretion of growth hormone into seminal fluid. Nature Biotechnology 17: 1087-1090.

Eric A. Wong
Department of Animal and Poultry Sciences
Virginia Tech
ewong@vt.edu



GM PRODUCT LABELING CATERS FOOD FOR THOUGHT

For good reason, Science magazine has designated the debate over genetically modified (GM) foods as the "controversy of the year." Throughout the world, there have been numerous manifestations of the backlash against GM crops and food derived from GM crops. The European Union (EU), for example, has decided to suspend the introduction of new GM crops pending legislation, which may take three years to resolve. Meanwhile, Japan's health ministry recently announced that it would not approve any more GM foods, pending the introduction of tighter regulations next April. Even Monsanto's caterer for the United Kingdom headquarters banned GM food from the staff cafeteria. In the United States, the summer and fall of 1999 saw an intensification of protests, including the damage of private and university research plots.

One position that various governments have adopted is that GM crops and food allowed in the market must be labeled as such. GM product labeling is required in Britain and Switzerland, and is under EU regulations, while Japan and South Korea plan to implement labeling requirements. At present, there is no mandatory requirement for labeling GM products in the US. This is a situation that activists are trying to change using a number of justifications, including the unsupported allegation that GM food is not safe. The issue of food safety falls within the purview of the Food and Drug Administration (FDA).

Labeling Safely

Under the Federal Food, Drug, and Cosmetic Act, the FDA has the authority to ensure the safety and wholesomeness of most foods, except meat and poultry. In 1992, the FDA published a policy statement on the regulation of foods and animal feeds derived from new plant varieties developed by genetic engineering techniques. An evaluation of the safety and nutritional composition of food derived from GM plants relies upon information pertaining to the agronomic and quality attributes of the plant, genetic analysis of the modification and stability of expected genomic traits, evaluation of the safety (i.e., toxicity and allergenicity) of any newly introduced proteins, and chemical analysis of important toxicants and nutrients. The FDA requires pre-market approval for molecules (proteins, fatty acids, carbohydrates, etc.) produced by introduced genes, if these molecules differ substantially in structure and function from typical molecules found in foods.

A basic principle of the 1992 policy is that the FDA uses a science-based approach for ensuring the safety of foods from new plant varieties. The FDA focuses its evaluation on the objective characteristics of the food or its components, rather than the fact that new development methods were used, at some point, to produce the food. Accordingly, the Agency has not required labeling for other non-GM methods of plant breeding, such as chemical-induced or radiation-induced mutation, somaclonal variation, or cell culture.

Labeling Religiously

In May 1998, the Alliance for Bio-Integrity filed a lawsuit against the FDA seeking to institute mandatory labeling of all GM foods1. The suit alleged, among other things, that current FDA policy violates the freedom of certain religions that adhere to dietary laws. Anti-GM food activists often raise this religion-based issue as a justification for labeling. This argument, however, does not seem particularly compelling. For example, both Orthodox Rabbis and Muslim leaders have decided that simple gene additions, which lead to one or a few new components in a species, are acceptable for kosher and halal law2. Although animal-to-plant gene transfers could cause concern for people adhering to certain dietary restrictions, the FDA has pointed out that no such products are yet marketed, and that the Agency would have the opportunity to consider such a case if it arises.

The Vatican's Pontifical Academy for Life recently announced its decision that modifying the genes of plant and animals is theologically acceptable3. Nevertheless, the vice-president of the Academy stated that consumers must be informed about GM products through proper labeling. This ill-defined "right to know" is another popular justification for labeling.

Labeling Righteously

During November, the US House of Representatives introduced H.R. 3377, a bill that would require the following notice on foods derived from GM crops: "Genetically engineered; United States government notice: This product contains genetically engineered material, or was produced with a genetically engineered material." The bill suggests that qualifying food would contain as low as 0.10 percent GM ingredients, a standard that is ten times more strict than the EU requirement. Representative Dennis Kucinich (D-OH), who co-sponsored the bill, explained, presumably sincerely, that no one is suggesting that GM food is dangerous, but, "If we are what we eat, then consumers must know what they are eating." One of the doctrines of the legislation is that the process of genetically engineering foods results in the material change of such foods. This material change seems to be one of perception, and not based on fact.

H.R. 3377 is subtitled "Genetically Engineered Food Right to Know Act." Yet the Federal Food, Drug, and Cosmetic Act does not require disclosure in labeling of information solely based on the consumers' desire to know. According to the FDA's interpretation of the Act, the agency does not even have the authority to mandate labeling based solely upon a consumer's right to know the method of production if the final product is considered safe. And, despite the hoary cliché, there simply is no overriding "right to know" principle.

A federal appellate court clearly made this point in the International Dairy Foods Association case4. Dairy manufacturers challenged the constitutionality of a Vermont statute that required identification of products that were, or might have been, derived from dairy cows treated with recombinant bovine somatotropin. The appellate court agreed with the dairy manufacturers that the labeling law was contrary to the constitutional right not to speak. Moreover, the court noted that Vermont defended the statute, not on any health or safety concerns, but on the basis of the public's right to know. The court found that consumer curiosity is insufficient to justify compromising protected constitutional rights, and the court noted that it was unaware of any case in which consumer interest alone was sufficient to justify a requirement that is the functional equivalent of a warning about a production method that has no discernible impact on the final product.

Labeling Voluntarily

Agriculture Secretary Glickman told Consumer Reports, "Frankly, if the consumers demand labeling—even if we think it doesn't convey a lot of good stuff—we're probably going to end up with a labeling scheme"5. There have been several reports that the USDA is advocating a labeling plan intended to meet demands of the European market. This plan complements the USDA's decision that a GM product would not qualify for certification as "organic." Moreover, in addition to the House's labeling bill, Senator Tom Hayden (D-CA) recently promised to introduce legislation that would require labeling of GM seeds, as well as GM raw and processed food. It is possible, therefore, that mandatory labeling will materialize by sheer momentum.

While the labeling of GM food may be a matter of time, the manner in which this change is brought about is of consequence. The institution of mandatory labeling forces a paradigm shift on the FDA from product-driven regulation to process-driven regulation, and from science-based regulation to a regulatory system grounded in social, political, and economic criteria. This change may well increase the consumer confusion that labels are supposed to prevent. As the International Dairy Foods Association court noted, if consumer interest alone were sufficient, then there would be no end to the information that manufacturers could be forced to disclose on labels.

The first generation of transgenic plants had input traits designed to affect methods and costs of production. In contrast, the next generation of transgenic plants contains output traits designed to alter particular properties in the final product in response to consumer preferences. As an example, Monsanto recently announced the development of a new variety of rape seed plant that produces oil enriched in beta-carotene—the compound that the human body converts into vitamin A.

As this new generation of GM food products enters the marketplace, it is likely that manufacturers will voluntarily include information about their enhanced GM-based ingredients. Of course, voluntary labeling is unlikely to appease those anti-GM food activists who have experienced a funding windfall created by the GM food debate.

Sources

1. Alliance for Bio-Integrity et al. v. Donna Shalala et al., Civil Action No. 98-1300 (D.D.C., filed May 27, 1998).

2. Vogt, Donna U. and Parish, Mickey. 1999. Food biotechnology in the United States: Science, regulation, and issues. Congressional Research Service Report to Congress. Available: http://www.usia.gov/topical/global/biotech/

3. Barnett, Antony. 1999. Vatican theologians say "prudent yes" to GM foods. The Observer, 28 November, 13.

4. International Dairy Foods Association et al. v. Amestoy and Graves, 93 F.3d 67 (2nd Cir. 1996).

5. Seeds of Change. 1999. Consumer Reports, September, 41-46.

Phillip B. C. Jones, PhD., J.D.
Seattle, Washington
pbcj@wolfenet.com




ISB News Report
120 Engel Hall
Virginia Tech
Blacksburg, VA 24061

The material in this News Report is compiled by NBIAP's Information Systems for Biotechnology, a joint project of USDA/CSREES and the Virginia Polytechnic Institute and State University. It does not necessarily reflect the views of the U.S. Department of Agriculture or of Virginia Tech. The News Report may be freely photocopied or otherwise distributed without charge.

Ruth Irwin, Editor (rirwin@nbiap.biochem.vt.edu)

To have the News Report automatically emailed to you, send an email message to news@nbiap.biochem.vt.edu and type subscribe newsreport [your_name] in the message section. Do not include a signature file or additional text. Connect to http://www.isb.vt.edu for internet access to ISB News Reports, textfiles, and databases.

Information Systems for Biotechnology, 120 Engel Hall, Virginia Polytechnic Institute and State University, Blacksburg, VA 24061, tel: 540-231-2620, fax: 540-231-2614, email: isb@vt.edu